Correlation Between Iovance Biotherapeutics and Exelixis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Iovance Biotherapeutics and Exelixis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iovance Biotherapeutics and Exelixis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iovance Biotherapeutics and Exelixis, you can compare the effects of market volatilities on Iovance Biotherapeutics and Exelixis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iovance Biotherapeutics with a short position of Exelixis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iovance Biotherapeutics and Exelixis.

Diversification Opportunities for Iovance Biotherapeutics and Exelixis

0.36
  Correlation Coefficient

Weak diversification

The 3 months correlation between Iovance and Exelixis is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Iovance Biotherapeutics and Exelixis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exelixis and Iovance Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iovance Biotherapeutics are associated (or correlated) with Exelixis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exelixis has no effect on the direction of Iovance Biotherapeutics i.e., Iovance Biotherapeutics and Exelixis go up and down completely randomly.

Pair Corralation between Iovance Biotherapeutics and Exelixis

Given the investment horizon of 90 days Iovance Biotherapeutics is expected to under-perform the Exelixis. In addition to that, Iovance Biotherapeutics is 1.31 times more volatile than Exelixis. It trades about -0.22 of its total potential returns per unit of risk. Exelixis is currently generating about -0.02 per unit of volatility. If you would invest  3,450  in Exelixis on November 9, 2024 and sell it today you would lose (83.00) from holding Exelixis or give up 2.41% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Iovance Biotherapeutics  vs.  Exelixis

 Performance 
       Timeline  
Iovance Biotherapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Iovance Biotherapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Exelixis 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Exelixis has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent technical and fundamental indicators, Exelixis is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.

Iovance Biotherapeutics and Exelixis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Iovance Biotherapeutics and Exelixis

The main advantage of trading using opposite Iovance Biotherapeutics and Exelixis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iovance Biotherapeutics position performs unexpectedly, Exelixis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exelixis will offset losses from the drop in Exelixis' long position.
The idea behind Iovance Biotherapeutics and Exelixis pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio